Summary:
A Randomized, Double-Blind, Placebo‑Controlled Study to Assess the Efficacy and Safety of NYX-2925 in Subjects with Neuropathic Pain Associated with Diabetic Peripheral Neuropathy
Qualified Participants Must:
• Have type 2 diabetes
•
Have neuropathy in both legs or feet for more than 4 years
Qualified Participants May Receive:
Treatment for their neuropathy at no cost to them